Subscribed capital
The Company’s subscribed capital amounted to EUR 31,862 thousand as at December 31, 2025 and December 31, 2024 and is fully paid up. It is divided into 31,862,400 no-par value registered shares, which entitle the shareholders to the dividend resolved in each case and to one vote per share at the Company’s Annual General Meetings. The subscribed capital is the capital to which the liability of the shareholders for the Company’s liabilities to creditors is limited. The Company’s assets required to maintain the subscribed capital may not be paid out to shareholders.
Authorized and contingent capital
By resolution of the Annual General Meeting on May 13, 2025, the Management Board is authorized, with the approval of the Supervisory Board, to increase the Company’s share capital on one or more occasions on or before May 12, 2030 (including that date) by up to a total of EUR 3,186,240 by issuing up to 3,186,240 new no-par value registered shares in return for cash contributions and/or contributions in kind, whereby shareholders’ subscription rights may be excluded (Authorized Capital 2025).
By resolution of the Annual General Meeting of May, 13, 2025, the share capital of the Company is conditionally increased by up to EUR 3,186,240 by issuing up to 3,186,240 new no-par value registered shares for the purpose of granting convertible bonds and/or bonds with warrants (2025 contingent capital).
Capital reserve
The capital reserve contains:
•amounts (premiums) received for the issuance of shares,
•premiums paid by shareholders in exchange for the granting of a preference for their shares,
•amounts from other additional payments made by shareholders into equity.
The capital reserve in the separate financial statements of NORMA Group SE according to HGB amounts to EUR 116,601 thousand.
Retained earnings
Retained earnings changed as follows during the reporting period:
| | | | | | | | | | |
Development of retained earnings |
|
|---|
in EUR thousands | Retained earnings | Remeasurement of the net defined benefit liability | Share-based payments | IPO costs directly netted with equity | Reimbursement of IPO costs by share-holders | Acquisition
of non-
controlling interest | Effects from retrospective application of IAS 19R | Effects of FRS 9 | Effects of IFRS 16 | Total |
|---|
Balance as of Jan 1, 2024 | 451,917 | 792 | 666 | -4,640 | 4,681 | -6,359 | 839 | -600 | -2,033 | 445,263 |
|---|
Profit (loss) for the period | 14,696 |
|
|
|
|
|
|
|
| 14,696 |
|---|
Dividends paid | -14,338 |
|
|
|
|
|
|
|
| -14,338 |
|---|
Share-based payments |
|
| 71 |
|
|
|
|
|
| 71 |
|---|
Effect before taxes |
| -62 |
|
|
|
|
|
|
| -62 |
|---|
Tax effect |
| -11 |
|
|
|
|
|
|
| -11 |
|---|
Balance as of Dec 31, 2024 | 452,275 | 719 | 737 | -4,640 | 4,681 | -6,359 | 839 | -600 | -2,033 | 445,619 |
|---|
Balance as of Jan 1, 2025 | 452,275 | 719 | 737 | -4,640 | 4,681 | -6,359 | 839 | -600 | -2,033 | 445,619 |
|---|
Profit (loss) for the period | -81,753 |
|
|
|
|
|
|
|
| -81,753 |
|---|
Dividends paid | -12,745 |
|
|
|
|
|
|
|
| -12,745 |
|---|
Share-based payments |
|
| 56 |
|
|
|
|
|
| 56 |
|---|
Effect before taxes |
| 1,040 |
|
|
|
|
|
|
| 1,040 |
|---|
Tax effect |
| -230 |
|
|
|
|
|
|
| -230 |
|---|
Balance as of Dec 31, 2025 | 357,777 | 1,529 | 793 | -4,640 | 4,681 | -6,359 | 839 | -600 | -2,033 | 351,987 |
|---|
After the Annual General Meeting in May 2025, a dividend of EUR 12,745 thousand (EUR 0.40 per share) was paid to the shareholders of NORMA Group.
Other reserves
Other reserves consisted of the following:
| | | |
Development of other reserves |
|
|---|
in EUR thousands | Cash flow hedges | Currency translation differences on translating foreign operations | Total |
|---|
Balance as of Jan 1, 2024 | 3,159 | 2,495 | 5,654 |
|---|
Effect before taxes | -1,566 | 28,682 | 27,116 |
Tax effect | 420 | | 420 |
Balance as of Dec 31, 2024 | 2,013 | 31,177 | 33,190 |
|---|
Effect before taxes | -2,494 | -61,835 | -64,329 |
Tax effect | 784 |
| 784 |
Balance as of Dec 31, 2025 | 303 | -30,658 | -30,355 |
|---|
Legend
These contents are part of the Non-financial Group Report and were subject to a separate limited assurance examination.